Page last updated: 2024-08-16

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and ecopipam

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with ecopipam in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acquas, E; Di Chiara, G2
Ikeda, K; Ikejiri, M; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Ogi, Y1

Other Studies

3 other study(ies) available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and ecopipam

ArticleYear
Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
    European journal of pharmacology, 1999, Oct-27, Volume: 383, Issue:2

    Topics: Acetylcholine; Animals; Benzazepines; Benzopyrans; Dopamine; Dopamine Agonists; Dopamine Antagonists; Feedback; Male; Neostriatum; Oxazines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3

1999
Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1

    Topics: Acetylcholine; Benzazepines; Benzopyrans; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Microdialysis; Neostriatum; Neurons; Oxazines; Quinpirole; Receptors, Dopamine D1

2001
The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Behavioural brain research, 2016, Mar-01, Volume: 300

    Topics: Acetamides; Animals; Apomorphine; Benzamides; Benzazepines; Benzopyrans; Blinking; Callithrix; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Male; Models, Animal; Oxazines; Piperazines; Pyridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4

2016